Similar articles for PMID: 20607405

Year	Number of Results
1996	1
1997	1
1999	3
2000	3
2001	3
2002	7
2003	7
2004	4
2005	2
2006	7
2007	14
2008	12
2009	10
2010	12
2011	7
2012	2
2013	4
2014	7
2015	1
2016	2
2017	2
2018	2
2021	2
2022	1
2024	0

1

Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease.

Kierkus J, Furmaga-Jablonska W, Sullivan JE, David ES, Stewart DL, Rath N, Fu C, Wang W, Maguire MK, Comer GM. Kierkus J, et al. Dig Dis Sci. 2011 Feb;56(2):425-34. doi: 10.1007/s10620-010-1321-3. Epub 2010 Jul 7. Dig Dis Sci. 2011. PMID: 20607405 Clinical Trial.

2

Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year.

Springer M, Atkinson S, North J, Raanan M. Springer M, et al. Paediatr Drugs. 2008;10(4):255-63. doi: 10.2165/00148581-200810040-00004. Paediatr Drugs. 2008. PMID: 18590344 Clinical Trial.

3

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).

Ward RM, Tammara B, Sullivan SE, Stewart DL, Rath N, Meng X, Maguire MK, Comer GM. Ward RM, et al. Eur J Clin Pharmacol. 2010 Jun;66(6):555-61. doi: 10.1007/s00228-010-0811-8. Epub 2010 Mar 20. Eur J Clin Pharmacol. 2010. PMID: 20306184 Clinical Trial.

4

Age-dependent pharmacokinetics of lansoprazole in neonates and infants.

Zhang W, Kukulka M, Witt G, Sutkowski-Markmann D, North J, Atkinson S. Zhang W, et al. Paediatr Drugs. 2008;10(4):265-74. doi: 10.2165/00148581-200810040-00005. Paediatr Drugs. 2008. PMID: 18590345 Clinical Trial.

5

Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.

López-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macías M, Silny J, Sifrim D. López-Alonso M, et al. Pediatrics. 2006 Aug;118(2):e299-308. doi: 10.1542/peds.2005-3140. Epub 2006 Jul 10. Pediatrics. 2006. PMID: 16831894

6

Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through <6 years with gastro-oesophageal reflux disease.

Tammara BK, Sullivan JE, Adcock KG, Kierkus J, Giblin J, Rath N, Meng X, Maguire MK, Comer GM, Ward RM. Tammara BK, et al. Clin Pharmacokinet. 2011 Aug;50(8):541-50. doi: 10.2165/11591900-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21740077 Clinical Trial.

7

Impact of pantoprazole on duodeno-gastro-esophageal reflux (DGER).

Kunsch S, Neesse A, Linhart T, Steinkamp M, Fensterer H, Adler G, Gress TM, Ellenrieder V. Kunsch S, et al. Z Gastroenterol. 2009 Mar;47(3):277-82. doi: 10.1055/s-2008-1027865. Epub 2009 Mar 11. Z Gastroenterol. 2009. PMID: 19280541

8

Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (GERD): a prospective, multicenter, post-marketing observational study.

Remes-Troche JM, Sobrino-Cossío S, Soto-Pérez JC, Teramoto-Matsubara O, Morales-Arámbula M, Orozco-Gamiz A, Tamayo de la Cuesta JL, Mateos G. Remes-Troche JM, et al. Clin Drug Investig. 2014 Feb;34(2):83-93. doi: 10.1007/s40261-013-0135-4. Clin Drug Investig. 2014. PMID: 24347282 Clinical Trial.

9

Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study.

Wilder-Smith C, Backlund A, Eckerwall G, Lind T, Fjellman M, Röhss K. Wilder-Smith C, et al. Clin Drug Investig. 2008;28(6):333-43. doi: 10.2165/00044011-200828060-00001. Clin Drug Investig. 2008. PMID: 18479175 Clinical Trial.

10

Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.

Simon B, Müller P, Pascu O, Gatz G, Sander P, Huber R, Mascher H. Simon B, et al. Eur J Gastroenterol Hepatol. 2003 Jul;15(7):791-9. doi: 10.1097/01.meg.0000059157.46867.42. Eur J Gastroenterol Hepatol. 2003. PMID: 12811310 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year